SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-007652
Filing Date
2024-01-12
Accepted
2024-01-12 17:16:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d596366ds3.htm S-3 199739
2 EX-5.1 d596366dex51.htm EX-5.1 10030
3 EX-23.1 d596366dex231.htm EX-23.1 1851
4 EX-FILING FEES d596366dexfilingfees.htm EX-FILING FEES 19503
5 GRAPHIC g596366g31k62.jpg GRAPHIC 4065
6 GRAPHIC g596366g44w42.jpg GRAPHIC 47749
7 GRAPHIC g596366g77v37.jpg GRAPHIC 29529
  Complete submission text file 0001193125-24-007652.txt   337643
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276504 | Film No.: 24532839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)